Key Details
Price
$2.21PE Ratio
20.05Annual ROE
3.52%Beta
0.87Events Calendar
Next earnings date:
May 9, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 23, 2013Analyst ratings
Recent major analysts updates
Sep 9, 24 HC Wainwright & Co.
NeutralMay 20, 24 HC Wainwright & Co.
NeutralMay 17, 23 Canaccord Genuity
HoldJan 17, 23 HC Wainwright & Co.
NeutralJan 12, 23 Canaccord Genuity
HoldMay 16, 22 Aegis Capital
BuyFeb 18, 22 Cantor Fitzgerald
OverweightNov 30, 21 HC Wainwright & Co.
BuyNov 29, 21 HC Wainwright & Co.
BuyNov 2, 21 Aegis Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Oramed Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Oramed Pharmaceuticals?
- Does Oramed Pharmaceuticals pay dividends?
- What sector is Oramed Pharmaceuticals in?
- What industry is Oramed Pharmaceuticals in?
- What country is Oramed Pharmaceuticals based in?
- When did Oramed Pharmaceuticals go public?
- Is Oramed Pharmaceuticals in the S&P 500?
- Is Oramed Pharmaceuticals in the NASDAQ 100?
- Is Oramed Pharmaceuticals in the Dow Jones?
- When was Oramed Pharmaceuticals's last earnings report?
- When does Oramed Pharmaceuticals report earnings?
- Should I buy Oramed Pharmaceuticals stock now?
What is the ticker symbol for Oramed Pharmaceuticals?
The ticker symbol for Oramed Pharmaceuticals is NASDAQ:ORMP
Does Oramed Pharmaceuticals pay dividends?
No, Oramed Pharmaceuticals does not pay dividends
What sector is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Healthcare sector
What industry is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Biotechnology industry
What country is Oramed Pharmaceuticals based in?
Oramed Pharmaceuticals is headquartered in United States
When did Oramed Pharmaceuticals go public?
Oramed Pharmaceuticals's initial public offering (IPO) was on May 1, 2007
Is Oramed Pharmaceuticals in the S&P 500?
No, Oramed Pharmaceuticals is not included in the S&P 500 index
Is Oramed Pharmaceuticals in the NASDAQ 100?
No, Oramed Pharmaceuticals is not included in the NASDAQ 100 index
Is Oramed Pharmaceuticals in the Dow Jones?
No, Oramed Pharmaceuticals is not included in the Dow Jones index
When was Oramed Pharmaceuticals's last earnings report?
Oramed Pharmaceuticals's most recent earnings report was on Nov 7, 2024
When does Oramed Pharmaceuticals report earnings?
The next expected earnings date for Oramed Pharmaceuticals is May 9, 2025
Should I buy Oramed Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions